Oppn gives notice in RS for PM explanation on 'Pak conspiracy'

Agencies
December 15, 2017

New delhi, Dec 15: Opposition leaders today protested the rejection of their notice in the Rajya Sabha demanding an explanation and apology from Prime Minister Narendra Modi over his "conspiracy with Pakistan" remark involving his predecessor Manmohan Singh.

The leaders termed the comment "unfortunate" and told reporters outside the House it was "disappointing" that Rajya Sabha chairman M Venkaiah Naidu did not allow a discussion on the notice.

They also objected to the "illegal disqualification" of rebel Janata Dal (United) leaders Sharad Yadav and Ali Anwar Ansari.

In place of Yadav and Ansari, Bihar Chief Minister and JD(U) president Nitish Kumar should be disqualified for breaking away from the grand alliance with the Rashtriya Janata Dal and the Congress, they said.

"We gave a notice, but the chairman adjourned the House and did not let us raise the issue. We are disappointed. The chairman should have given us permission. This is a national... international issue," Leader of Opposition in the Rajya Sabha Ghulam Nabi Azad told reporters.

At an election rally in Gujarat on Sunday, Modi had suggested that Pakistan was trying to influence the state assembly polls.

He had claimed that some Pakistani officials and Manmohan Singh met at Congress leader Mani Shankar Aiyar's house over dinner on December 6.

Azad said the prime minister should come to the Rajya Sabha and explain his remarks to its members.

His party colleague Anand Sharma, Naresh Agarwal of the SP and D Raja of the CPI said the people concerned should be punished if the allegations levelled by Modi were true.

"But if it is false, if he levelled such a big allegation to polarise the people in view of the Gujarat polls, then he should apologise not only to the House but also to the people of the country," Azad said.

Raja said it was "not correct" on Modi's part to cast aspersions on Singh.

The CPI national secretary said Modi should have called up his predecessor if he had any information on the "conspiracy" issue.

"He should have done it, but the way he raised the issue in an election campaign... It is highly objectionable. It is not good for democracy," Raja said, asking the government to respect the Opposition.

Sharma said it was "undemocratic" that the Opposition's voice was being "muzzled".

He said the prime minister was "aware" of the notice and could have "used the opportunity to clarify his remarks, express regret and apologise".

"But the prime minister and the dispensation are arrogant and confrontational. And this is most unfortunate. This attitude does not augur well for democracy. It is an ominous development on the first day itself," Sharma said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 10,2020

New Delhi, May 10: India's COVID-19 count crossed 60 thousand on Sunday, with Maharashtra being the worst-affected due to the infection so far, according to the Union Ministry of Health and Family Welfare.

The number of total confirmed cases in the country rose to 62,939, including 19,358 patients who have been cured and discharged or migrated, according to the Ministry.

The total number of active cases in the country, therefore, stands at 41,472.

The number of deaths in the country due to the infection reached 2,109 on Sunday.

While Maharashtra, with 20,228 cases is the worst-affected state, it is followed by Gujarat with 7,796 and the national capital, Delhi, with 6,542 cases. Tamil Nadu, is marginally behind Delhi with 6,535 cases.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 11,2020

Kochi, Jul 11: Johnny Paul Pierce's five-month stay in Kerala has been a soul-soothing experience for 74-year-old US citizen. He now wants to spend the rest of his life here.

"Kerala is a beautiful place to live in. This is my fifth trip here. I usually stay here for six months. It is such a magical place to be and I want to share that with people from the US," Pierce told ANI.

He came to India on February 26 on a tourist visa and is staying at Kandanadu in Kochi.

According to Pierce's Advocate, his tourist visa is valid up to January 26, 2025. But on this visa, he can only stay consecutively for 180 days.

The guidelines of the Indian government permit continuous stay for only 180 days for foreigners on tourist visas. His 180 days were set to expire on August 24, which the Foreigner Regional Registration Office (FRRO) extended to August 30.

The US citizen has approached the Kerala High Court seeking to convert his tourist visa into a business visa. The petition will be considered next week.

Pierce has sought a directive to the government to permit him to apply for the conversion of his tourist visa into a business visa and also to extend his stay, without having to leave the country.

"I am making a petition for an extra 180 days to stay. And I would also like to get a business visa in order to begin a tour company to bring people from the US to Kerala after the coronavirus. I wish my family could also come here. I am very impressed with what's is happening here. People in the US don't care about COVID-19," he said.

He talked about the risk of going back to his home country saying, "There are only 27 deaths in Kerala and in the US there over 1.3 lakh deaths. I do not want to go back to the US. I am 74 years old and I am at risk. This is a very safe place for me. I hope India embraces and allows me to stay."

"There's chaos in the US due to COVID-19 and government is not taking care like India. I want to stay here," he added.

Pierce further talked about his future plans, saying that if he is allowed to stay, he would like to lease a small resort and make a retirement community, which will be a COVID free zone.

Lastly, he made an appeal to the Indian government to let him stay in India saying that "all the immigration rules were made before COVID-19."

"There should be special consideration for people like me," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.